Skip to main content
U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Beta This is a new resource - your feedback will help us improve it.

Series: Mandatory Review of HHS Agencies' Annual Accounting of National Drug Control Program Funds

Announced on  | Last Modified on  | Series Number: SRS-A-26-009

OBJECTIVE

The Office of National Drug Control Policy circular: National Drug Control Program Agency Compliance Reviews requires agencies expending funds on National Drug Control Program activities to submit an accounting of such funds made during the previous fiscal year (21 U.S.C. § 1704). The policy also requires that an agency submit with its annual accounting an authentication provided by the agency's OIG that expresses a conclusion on the reliability of the agency's assertions. The circular states that if in an agency's prior year drug-related obligations were less than $50 million, the agency would not be subject to these authentication requirements. We will review how HHS agencies complied with this circular and will submit the authentication with respect to the HHS agencies' annual accounting, beginning with FY 2020, once every three years.

There are 7 projects in this series.

Project titles will remain unpublished until projects are complete and reports are posted.

ACTIVE PROJECTS IN THIS SERIES (2)

COMPLETED PROJECTS IN THIS SERIES (5)

OAS-26-03-023

OAS-26-03-024

OAS-26-03-025

CMS Fiscal Year 2024 Detailed Accounting Submission and Fiscal Year 2026 Budget Formulation Compliance Report for National Drug Control Activities, and the Accompanying Required Assertions

HRSA Fiscal Year 2024 Detailed Accounting Submission and Fiscal Year 2026 Budget Formulation Compliance Report for National Drug Control Activities, and the Accompanying Required Assertions

TIMELINE

  • October 29, 2024
    Projects Announced

    CMS Fiscal Year 2024 Detailed Accounting Submission and Fiscal Year 2026 Budget Formulation Compliance Report for National Drug Control Activities, and the Accompanying Required Assertions - OAS-25-03-018

  • HRSA Fiscal Year 2024 Detailed Accounting Submission and Fiscal Year 2026 Budget Formulation Compliance Report for National Drug Control Activities, and the Accompanying Required Assertions - OAS-25-03-016

  • January 15, 2025
    Project Complete - OAS-25-03-018

    CMS Fiscal Year 2024 Detailed Accounting Submission and Fiscal Year 2026 Budget Formulation Compliance Report for National Drug Control Activities, and the Accompanying Required Assertions complete. Report Published

  • January 15, 2025
    Project Complete - OAS-25-03-016

    HRSA Fiscal Year 2024 Detailed Accounting Submission and Fiscal Year 2026 Budget Formulation Compliance Report for National Drug Control Activities, and the Accompanying Required Assertions complete. Report Published

  • December 19, 2025
    Series Number SRS-A-26-009 Assigned
  • December 19, 2025
    Projects Announced

    OAS-26-03-023 - OAS-26-03-023

  • OAS-26-03-024 - OAS-26-03-024

  • OAS-26-03-025 - OAS-26-03-025

  • February 24, 2026
    Project Complete - OAS-26-03-023

    OAS-26-03-023 complete. Report Published

  • February 24, 2026
    Project Complete - OAS-26-03-024

    OAS-26-03-024 complete. Report Published

  • February 24, 2026
    Project Complete - OAS-26-03-025

    OAS-26-03-025 complete. Report Published

  • February 24, 2026
    Series Complete

    Mandatory Review of HHS Agencies' Annual Accounting of National Drug Control Program Funds complete.

  • November 2, 2026
    Projects Announced

    Project OAS-27-03-007

  • Project OAS-27-03-008

5 REPORT PUBLISHED


-